St Jude takes EnSite system to Japan:
This article was originally published in Clinica
Japanese regulators have given St Jude Medical regulatory and reimbursement approvals for its computer-based visualisation and navigation tool for use in treating irregular heartbeats. The EnSite system allows electrophysiologists to create three-dimensional models of their patients' cardiac anatomy and identify the location and movement of abnormal electrical impulses, enabling a treatment strategy to be determined. The St Paul, Minnesota firm's device is being distributed in Japan by Nihon Kohden.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.